PI3K/AKT signaling axis controls GSK3β dependent regulation of MYCN and stabilization of HIF1α and hence the efficacy of inhibitors targeting these signaling axes has been tested in NB models [22,23,24]. This evidence concerns the gene HIF1A and neuroblastoma.